Mad Money Lightning Round

Mad Money Lightning Round Recent News

Jim Cramer Recommends Staying Long On This Industrial Stock
Jim Cramer Recommends Staying Long On This Industrial Stock
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended staying long on Watts Water Technologies, Inc. (NYSE: WTS).
Jim Cramer Says 'No' To Ambarella, But Gilat Satellite Is Still A 'Buy'
Jim Cramer Says 'No' To Ambarella, But Gilat Satellite Is Still A 'Buy'
On CNBC's "Mad Money Lightning Round," Jim Cramer discusses Rivian, Energy Fuels, Gilat Satellite, Ambarella and AST SpaceMobile.
Jim Cramer: This Basic Materials Stock Has Gone Up So Much, Recommends Waiting For A 'Little Bit Of A Pullback'
Jim Cramer: This Basic Materials Stock Has Gone Up So Much, Recommends Waiting For A 'Little Bit Of A Pullback'
Mad Money's Jim Cramer takes a look at CMS Energy, Ramaco Resources, Accenture, Okta and Rocket Companies.
Cramer Backs Rubrik, Snubs Seagate's Rally
Cramer Backs Rubrik, Snubs Seagate's Rally
Jim Cramer's stock picks reveal a divergence from conventional wisdom. He likes Rubrik and SAP, but advises caution with Seagate and Eagle Materials.
'If It's Gold, It's Going Higher' — But Cramer Isn't Backing New Gold
'If It's Gold, It's Going Higher' — But Cramer Isn't Backing New Gold
Cramer picks Globalstar as a standout performer while preferring Agnico Eagle Mines over New Gold. Globalstar and New Gold report strong earnings.
Bloom Energy Is Not Jim Cramer's 'Cup Of Tea,' But It's Going Up
Bloom Energy Is Not Jim Cramer's 'Cup Of Tea,' But It's Going Up
Mad Money's Jim Cramer takes a look at QXO, Bloom Energy, Newmont, AllianceBernstein, Lam Research, LoanDepot and Centrus Energy.
Jim Cramer Recommends Buying This Industrial Stock, Calling It 'Way Too Cheap'
Jim Cramer Recommends Buying This Industrial Stock, Calling It 'Way Too Cheap'
"Mad Money" star Jim Cramer discusses MP Materials, Resideo Technologies and Canadian National Railway on Friday, Sept. 12.
Jim Cramer: This Is The Right Time To Buy This Energy Stock
Jim Cramer: This Is The Right Time To Buy This Energy Stock
Mad Money's Jim Cramer looks at Phillips 66 and Intuitive Surgical, as well as Tandem Diabetes Care and Cintas.
Cramer Won't Buy UnitedHealth Under Probe, But Says Some Think 'The Worst Is Over'
Cramer Won't Buy UnitedHealth Under Probe, But Says Some Think 'The Worst Is Over'
Investors scrutinize earnings as market volatility persists. Jim Cramer prefers growth and stability in stock picks. AGNC, UnitedHealth underperform.
Jim Cramer Urges Caution On Intel Rally, Says IBM Offers More Than D-Wave
Jim Cramer Urges Caution On Intel Rally, Says IBM Offers More Than D-Wave
Jim Cramer recommends Elbit Systems (ESLT) and Preformed Line Products (PLPC). Intel (INTC) and Gray Media (GTN) are also discussed.
Jim Cramer Expects Palantir To Reach New All-Time High
Jim Cramer Expects Palantir To Reach New All-Time High
Market analysts and financial commentators provide crucial guidance in the volatile investment landscape. Cramer says no to VKTX, but expects PLTR to go up.
Jim Cramer: Sell Chime, Get This Buy Now Pay Later Stock Instead
Jim Cramer: Sell Chime, Get This Buy Now Pay Later Stock Instead
Chime Financial, on Aug. 22, announced a strategic partnership with Workday to advance financial wellness in the workplace.
Jim Cramer Says Amphenol, EMCOR Group Are Worth Holding On To
Jim Cramer Says Amphenol, EMCOR Group Are Worth Holding On To
One is "good;" the other is "amazing," Cramer says. But regarding Circle Internet Group? It needs to come down.
Jim Cramer Says Rigetti May Have A 'Home Run' Opportunity — But It's Speculative
Jim Cramer Says Rigetti May Have A 'Home Run' Opportunity — But It's Speculative
Investors are captivated by shifts in the tech sector. Cramer's insights highlight stock movements. Opendoor is a meme stock. CEO stepped down. New collaborations for Rigetti Computing.
Jim Cramer: Kodiak Sciences Is A 'Pure Spec' Stock, Recommends Buying This Utilities Stock
Jim Cramer: Kodiak Sciences Is A 'Pure Spec' Stock, Recommends Buying This Utilities Stock
Kodiak Sciences posted a second-quarter loss of $1.03 per share, compared to market estimates of a loss of $1.02 per share.
Jim Cramer Recommends This Energy Stock, But Don't 'Bank It All' On Arcus
Jim Cramer Recommends This Energy Stock, But Don't 'Bank It All' On Arcus
On CNBC's Mad Money Lightning Round, Jim Cramer endorsed buying Uranium Energy and called Arcus Biosciences a speculative play.
Cramer Expects This FinTech To Reach $100, Upset With Eli Lilly: 'Come Back And Talk To Me'
Cramer Expects This FinTech To Reach $100, Upset With Eli Lilly: 'Come Back And Talk To Me'
Cramer says we are "too negative" on Eli Lilly. "I think they should come back on and talk to me," he adds.
Jim Cramer: This Financial Stock Is 'Just Too Dicey', Salesforce Is A 'Little Tough Right Now'
Jim Cramer: This Financial Stock Is 'Just Too Dicey', Salesforce Is A 'Little Tough Right Now'
Salesforce is a "little tough right now," Jim Cramer said. "I want to see what happens with the quarter."
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved